Drug
tildrakizumab-asmn
Marketed as ILUMYA.
Generic name
tildrakizumab-asmn
Brand names
ILUMYA
First FDA approval
2018-03-20
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761067 | ILUMYA | 2018-03-20 | SUN PHARMA GLOBAL |
Manufacturers
SUN PHARMA GLOBAL
Frequently asked questions
When was tildrakizumab-asmn FDA approved?
Earliest FDA approval on record: 2018-03-20.
What brand names are sold as tildrakizumab-asmn?
ILUMYA.
Sources
Appeal a tildrakizumab-asmn denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com